Clinical Trials in North Carolina

Showing 6361-6380 of 15,496 trials

The Impact of Cigarillo Warnings on Purchasing

NCT05434013

The purpose of this study is to determine whether different cigarillo warning formats (pictorial, FDA-proposed text-only, current Surgeon General text-only) reduces demand for cigarillos. A previous study has identified that pictorial cigarillo warnings are perceived as more effective, but more information is needed on their impact. This study will address this issue by randomizing participants to see different cigarillo warning formats on cigarillo products within an online experimental tobacco marketplace. Participants will be cigarillo users who are ages 21-35.

Cigar Smoking

Boston University1,578 participantsStarted Jun 2022

Winston-Salem, North Carolina, United States

TERMINATEDPhase 346 miles

A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

NCT03024996

This is a Phase III, multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of atezolizumab versus placebo in participants with RCC who are at high risk of disease recurrence following nephrectomy.

Renal Cell Carcinoma

Hoffmann-La Roche778 participantsStarted Jan 2017

Scottsdale, Arizona, United States • Duarte, California, United States • Lancaster, California, United States +183 more locations

The Impact of Cigarillo Warnings on Purchasing

A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

Find Trials by Condition in North Carolina

A Study of PRN1008 in Patients With Pemphigus

Ultrabrief Behavioral Activation for Reducing Alcohol Use

Family Health History in Diverse Care Settings (FHH)

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Look AHEAD: Action for Health in Diabetes

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

Evaluation of Rotation With a Multifocal Toric Contact Lens

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Fulvestrant + Neratinib In Breast Cancer

Evaluation of C-Scan Capsule in Identifying Subjects With Elevated Risk of Colon Polyps

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study